Hepatitis Tests, Profiles, and Panels by Thyrocare

• Anti Hepatitis B Envelope Antigen (AHBe)
• Hepatitis B Envelope Antigen (HBeAg)
• Anti Hepatitis B Core Antigen – IgM
• Anti Hepatitis B Core Antigen – Total
• Anti Hepatitis B Surface Antigen – Total
• Hepatitis B Surface Antigen (HBsAg)
• Anti Hepatitis C Virus (Anti-HCV)
• Anti Hepatitis A Virus (IgM)
• Anti Hepatitis A Virus – Total
• Anti Hepatitis E Virus (IgM)

• Liver function tests (LFT) including AST, ALT, bilirubin (total, direct, and indirect), alkaline phosphatase
• Gamma glutamyl transferase (GGT)
• Serum protein (total), albumin, and globulin
• Complete hemogram (CBC)
• HbA1c and average blood glucose

Used when comprehensive hepatitis blood tests across A, B, C, and E are required, together with liver function tests and blood health.

• Hepatitis B Surface Antigen (HBsAg)
• Hepatitis B Envelope Antigen (HBeAg)
• Anti Hepatitis B Envelope Antigen (AHBe)
• Anti Hepatitis B Core Antigen – IgM
• Anti Hepatitis B Core Antigen – Total
• Anti Hepatitis B Surface Antigen – Total

• Liver function tests including AST, ALT, bilirubin (direct, indirect, and total)
• Gamma glutamyl transferase
• Serum protein (total), globulin, and albumin
• Complete hemogram
• HbA1c and average glucose

Complete Hepatitis B antigen profile combined with supportive liver and blood health checkups.

• Antigens and antibodies for hepatitis A, B, C, and E
• Clinical significance notes for individual tests
• Methodologies used for different testing parameters
• Liver function tests with reference intervals
• HbA1c and average blood glucose with lab reference ranges
• Complete hemogram with blood count, indices, and platelet parameters
• Conditions of reporting and report structure notes

HBsAg is used as a screening test for Hepatitis B infection. It appears around 2 to 3 weeks before the onset of illness, reaching a peak during the illness phase, and disappearing in a self-limited infection within about 3 to 6 months. Persistence beyond that pattern can be seen in carrier states.

Anti-HBs is an antibody associated with recovery or immunity after Hepatitis B infection. The report notes that this antibody usually appears after HBsAg has disappeared from the blood and that a level of 10 mIU/mL or more is regarded as protective against Hepatitis B viral infection.

HBeAg is an antigen of active viral replication in Hepatitis B. It is detected in the early phase after HBsAg and is associated with increased numbers of infectious virions and the presence of HBV DNA and DNA polymerase in serum.

Anti-HBe becomes clinically relevant after the disappearance of HBeAg. Seroconversion from HBeAg to HBeAb during acute Hepatitis B is usually linked with resolution of infection and reduced infectivity.

Anti-HBc IgM supports the assessment of recent or acute Hepatitis B infection. It appears shortly after HBsAg and usually disappears within about six months, making it useful in laboratory findings.

Anti-HBc Total indicates exposure to the Hepatitis B virus. It appears during the incubation phase with HBsAg, shows infection with HBV, and remains positive for life in most individuals.

Anti-HAV IgM supports the assessment of acute Hepatitis A infection. Anti-HAV IgM appears in the acute phase, is nearly always detectable at symptom onset, and in many cases persists through the first month of illness and can remain detectable for up to about six months. Anti-HAV remains detectable for a lifetime and helps in evaluating past exposure or immunity.

Anti-HEV IgM is used in the evaluation of Hepatitis E. Hepatitis E is usually an acute infection, and pregnant women are at higher risk of fulminant hepatic failure. Interpretation still depends on the overall clinical picture and timing of testing.

Anti-HCV is used in screening for Hepatitis C exposure. HCV is a major cause of transfusion-associated non-A, non-B hepatitis, and repeated reactive anti-HCV screening results should be confirmed with supplementary or nucleic acid-based testing.

The panels include bilirubin, alkaline phosphatase, GGT, AST, ALT, serum proteins, albumin, globulin, and the albumin-globulin ratio. These parameters help assess liver cell injury, cholestatic pattern, bilirubin handling, and protein synthesis status alongside viral markers.

The hepatitis panel also includes HbA1c with average blood glucose and a complete hemogram. HbA1c adds glucose metabolic health evaluation, while CBC provides supporting information on white cells, red cells, hemoglobin, platelet count, and differential counts. These blood tests help to review how a hepatitis viral infection affects an individual’s overall health.

1. Select the required panel.
2. Share patient details (name, age, gender, complete address with area PIN code, email id, and phone number) through WhatsApp.
3. Select date and time for home collection appointment.
4. You will receive booking confirmation within a few minutes.
5. A trained phlebotomist will collect the sample as per the schedule.
6. Samples will be processed at Thyrocare’s NABL-accredited and ISO-certified labs.
7. You will receive digital reports as per the TAT.

A complete hepatitis panel screens for viral antigens and antibodies associated with Hepatitis A, B, C, and E. It helps identify active infections, past viral exposures, or immunity. This package also includes necessary supportive tests, such as complete hemogram (CBC) and liver function tests, to evaluate your overall liver health.

The Complete Hepatitis Panel is a comprehensive screening package that includes Hepatitis A, B, C, and E antigens and antibodies. The Hepatitis B Profile is specifically focused only on Hepatitis B antigens and antibodies. Both packages cover supportive liver function tests, HbA1c, and hemogram tests.

Hepatitis testing is usually recommended if you experience symptoms of liver inflammation like jaundice (yellowing of eyes or skin), dark urine, chronic fatigue, or abdominal pain. It is also advised if you have elevated liver enzymes (SGOT/SGPT) on a routine health checkup, or if you have had a known exposure to any hepatitis virus.

Hepatitis viruses directly attack the liver. While viral markers (like HBsAg or Anti-HCV) confirm the presence of the virus, Liver Function Tests (such as bilirubin, AST, ALT, and alkaline phosphatase) measure the actual extent of liver inflammation, cellular damage, and bile flow disruption.

A positive HBsAg test indicates an active Hepatitis B infection. It means the virus is currently present in your blood, and you can pass the virus to others. Depending on how long this marker has been positive, it can indicate either a recent or long-term infection.

Immunity is checked using the Anti-HBs (Hepatitis B Surface Antibody) test. If this test is positive (≥ 10 mIU/mL) and HBsAg is negative, it usually means you have successfully recovered from a past infection or you have developed immunity from the Hepatitis B vaccine.

No, a routine CBC cannot detect hepatitis. A CBC only measures red cells, white cells, and platelets. While it might show general signs of a viral infection or systemic inflammation, confirming hepatitis requires specific viral antigen and antibody blood tests.

Fasting is not required for viral hepatitis markers or the supportive HbA1c and complete hemogram tests included in these panels. However, avoiding a very heavy, fat-rich meal before sample collection can help keep your blood sample clear for accurate liver enzyme readings.